@article{CJCR1755,
author = {Bing Li and Yong Du and Hanfeng Yang and Yayong Huang and Jun Meng and Dongmei Xiao},
title = {Magnetic resonance imaging for prostate cancer clinical application},
journal = {Chinese Journal of Cancer Research},
volume = {25},
number = {2},
year = {2013},
keywords = {},
abstract = {As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. In clinical practice, magnetic resonance imaging (MRI) is one of the imaging tools for the evaluation of prostate cancer, the fusion of MRI or dynamic contrast-enhanced MRI (DCE-MRI) with magnetic resonance spectroscopic imaging (MRSI) is improving the evaluation of cancer location, size, and extent, while providing an indication of tumor aggressiveness. This review summarizes the role of MRI in the application of prostate cancer and describes molecular MRI techniques (including MRSI and DCE-MRI) for aiding prostate cancer management.},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/1755}
}